Secretome
  • Home
  • Leadership
  • News and Publications
    • News
    • Publications
Select Page

Young Hearts Run Free: Therapeutic Potential of Neonatal Human Cardiac Progenitor Cells Secretome

by Sudhish Sharma | Mar 3, 2017 | Journals, Uncategorized

Abstract Stem cell hypothesis of aging postulates that youthful stem cells have better intrinsic ability to repair/regenerate after an injury. Consistent with this hypothesis, current report by Sharma et al observed nCPCs transplantation post-MI was associated with...

Stem Cell Therapy For Congenital Heart Disease: Toward Translation

by Sudhish Sharma | Aug 10, 2015 | Journals, Uncategorized

Abstract Stem cell therapy has the optimistic goal of regenerating the myocardium as defined by regrowth of lost or destroyed myocardium. As applied to patients with heart failure, many confuse or limit the regenerative definition to just improving myocardial function...

Pediatric End-Stage Failing Hearts Demonstrate Increased Cardiac Stem Cells

by Sudhish Sharma | Aug 2, 2015 | Journals, Uncategorized

Abstract Background—We sought to determine the location, expression, and characterization of cardiac stem cells (CSCs) in children with end-stage heart failure (ESHF). We hypothesized ESHF myocardium would contain an increased number of CSCs relative to age-matched...

Cardiosphere Derived Cells from Pediatric End-Stage Heart Failure Patients Have Enhanced Functional Activity due to the Heat Shock Response Regulating the Secretome

by Sudhish Sharma | Apr 2, 2015 | Journals, Uncategorized

Abstract We have demonstrated that human neonatal cardiosphere derived cells (CDCs) derived from the young are more regenerative due to their robust secretome. However, it is unclear how the decompensated pediatric heart impacts the functional activity of their CDCs....

Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death

by Sudhish Sharma | Jun 5, 2014 | Journals, Uncategorized

Abstract Protein homeostatic regulators have been shown toameliorate single, loss-of-function protein diseases but not totreat broader animal disease models that may involve celldeath. Diseases often trigger protein homeostatic instabilitythat disrupts the delicate...

A Strong Regenerative Ability of Cardiac Stem Cells Derived From Neonatal Hearts

by Sudhish Sharma | Sep 11, 2012 | Journals, Uncategorized

Abstract Background—Human stem cells (CSCs) promote myocardial regeneration in adult ischemic myocardium. The regenerative capacity of CSCs in the very young patients with non-ischemic congenital heart defects has not been explored. We hypothesized that isolated...
« Older Entries
Next Entries »

Recent Posts

  • Maryland Stem Cell Research Commission Announces $4 Million in Grants to Drive Stem Cell Innovations
  • Secretome Therapeutics Appoints Margot Connor as Board Director and Assembles World-Class Clinical Advisory Board
  • Secretome Therapeutics Appoints Deepa Prasad as Chief Financial Officer
  • Neoprogen is now Secretome Therapeutics, in alignment with the company’s focus in revolutionizing cell therapy via neonatal cardiac progenitor cells (nCPCs) and their respective secretomes 
  • NeoProgen receives approval from U.S. FDA for a Phase I Study of The Safety And Early Efficacy of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) In Chronic Ischemic Heart Failure
  • Facebook
  • Twitter
  • Instagram
© 2022 Secretome | Reinecke-Design.com